Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil boosts plasma renin activity, influenced by control plasma renin activity and changes in sympathetic tone.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Six existing drugs may help block virus entry in COVID-19.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Spanlastic formulations improve rivaroxaban's oral anticoagulation efficiency.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Acitretin treats severe skin conditions but requires careful monitoring due to serious side effects.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Nocturnal calcium infusions improved a boy's severe rickets without causing hair loss.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

Nitrofurantoin may cause sub-acute cutaneous lupus erythematosus.

KRDQN effectively predicts adverse drug reactions with high accuracy and clear explanations.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Upadacitinib improved multiple immune-related conditions in one patient.

The FDA approved a new Pfizer drug for hair loss in teens.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

The P133R mutation in AKR1D1 enzyme causes harmful bile acid buildup, explaining related health issues.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.